Jci_page_head_homepage_01 Jci_page_head_homepage_02
Carole Peyssonnaux, Annelies S. Zinkernagel, Reto A. Schuepbach, Erinn Rankin, Sophie Vaulont, Volker H. Haase, Victor Nizet, Randall S. Johnson
Published in Volume 117, Issue 7
J Clin Invest. 2007; 117(7):1926–1932 doi:10.1172/JCI31370
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4
Upregulation of ferroportin in Albumin-Cre/VHLflox/flox mice.

(A) Immunostaining for ferroportin in duodenum and liver sections from WT and Albumin-Cre/VHLflox/flox mice. Solid arrow indicates a hepatocyte, dashed arrow a Kupffer cell. (B) Ferroportin expression in liver extracts of WT and Albumin-Cre/VHLflox/flox mice. (C) Ferroportin mRNA levels in livers of WT and Albumin-Cre/VHLflox/flox mice. Results are expressed as mean ± SD (n ≥ 4 in each group); statistical analysis was done using Student’s t test (unpaired, 2 tailed).